AIMOVIG vs HALFLYTELY

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 11, 2026·How we rate

Possible drug interaction. AIMOVIG and HALFLYTELY are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	HALFLYTELY
Rating	72/100	New
Pharmacy pays	—	~$10.09 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	BISACODYL AND POLYETHYLENE GLYCOL 3350 AND POTASSIUM CHLORIDE AND SODIUM BICARBONATE AND SODIUM CHLORIDE
Manufacturer	Amgen Inc	Braintree
Dosage forms	Injectable, Solution	Tablet, delayed release
Drug class	—	—
Boxed warning	None	None

aimovig halflytely

Rating

72/100

New

Pharmacy pays

—

~$10.09 /30

Type

Active ingredient

ERENUMAB-AOOE

BISACODYL AND POLYETHYLENE GLYCOL 3350 AND POTASSIUM CHLORIDE AND SODIUM BICARBONATE AND SODIUM CHLORIDE

Manufacturer

Amgen Inc

Braintree

Dosage forms

Injectable, Solution

Tablet, delayed release

Drug class

—

Boxed warning

None

Frequently asked questions

What is the difference between Aimovig and Halflytely?

Aimovig contains Erenumab-Aooe, while Halflytely contains Bisacodyl and Polyethylene Glycol 3350 and Potassium Chloride and Sodium Bicarbonate and Sodium Chloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.